Abstract
Like senile plaques, cerebral amyloid angiopathy (CAA) does not result from accumulation of the amyloid β(Aβ) protein alone, but also contains a number of other components, referred to as amyloid β-associated proteins. In this review we will discuss which proteins can be found in the cerebral vessel walls that are affected by CAA, what the possible source of these proteins is, and to what extent they might contribute to the pathogenesis of CAA. The data generated in our laboratory are in agreement with a pathogenesis of CAA that is different from that of the amyloidosis in senile plaques, although part of the amyloid-associated proteins in both these lesions may have the same parenchymal source. Since vascular malfunction is an independent risk factor for developing Alzheimer’s disease (AD), and CAA formation may depend on the interactions of Aβ with Aβ-associated proteins, pharmacological interference with these interactions may provide a new approach for treatment of AD and related cerebral vasculopathies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Verbeek, M.M., Eikelenboom, P., and de Waal, R.M.W. (1997) Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer’s disease, J. Neuropathol. Exp. Neurol. 56, 751–761.
Verbeek, M.M., Otte-Höller, I., Veerhuis, R., Ruiter, D.J., and de Waal, R.M.W. (1998) Distribution of Aß-associated proteins in cerebrovascular amyloid of Alzheimer’s disease, Acta. Neuropathol. 96, 628–636.
Eikelenboom, P. and Veerhuis, R. (1996) The role of complement and activated microglia in the pathogenesis of Alzheimer’s disease, Neurobiol. Aging 17, 673–680.
Kalaria, R.N. and Kroon, S.N. (1992) Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer’s disease, Biochem. Biophys. Res. Commun. 186, 461–466.
Eikelenboom, P. and Stam, F.C. (1984) An immonuhistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer’s dementia, Virchows Arch [Cell Pathol] 47, 17–25.
Kida, E., Choi Miura, N.H., and Wisniewski, K.E. (1995) Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer’s disease and Down’s syndrome brain, Brain Res. 685, 211–216.
Jiang, H., Burdick, D., Glabe, C.G., Cotman, C.W., and Tenner, A.J. (1994) ß-Amyloid activates complement by binding to a specific region of the collagen-like domain of the ClqA chain, J. Immunol. 152, 5050–5059.
Snyder, S.W., Wang, G.T., Barrett, L., Ladror, U.S., Casuto, D., Lee, C.M., Krafft, G.A., Holzman, R.B., and Holzman, T.F. (1994) Complement Clq does not bind monomeric 13- amyloid, Exp. Neurol. 128, 136–142.
Eikelenboom, P., Hack, C.E., Rozemuller, J.M., and Stam, F.C. (1989) Complement activation in amyloid plaques in Alzheimer’s dementia, Virchows Arch. B. Cell Pathol. Incl. Mol. Pathol. 56, 259–262.
Zhan, S.-S., Veerhuis, R., Kamphorst, W., and Eikelenboom, P. (1995) Distribution of beta amyloid associated proteins in plaques in Alzheimer’s disease and in the non-demented elderly, Neurodegeneration 4, 291–297.
Strauss, S., Bauer, J., Ganter, U., Jonas, U., Berger, M., and Volk, B. (1992) Detection of interleukin-6 and a-2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer’s disease patients, Lab. Invest. 66, 223–230.
Abraham, C.R., Selkoe, D.J., and Potter, H. (1988) Immunochemical identification of the serine protease inhibitor alpha-l-antichymotrypsin in the brain amyloid deposits of Alzheimer’s disease, Cell 52, 487–501.
Kawamata, T., Tooyama, I., Yamada, T., Walker, D.G., and McGeer, P.L. (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal human brain, Am. J. Pathol. 142, 1574–1585.
Shoji, M., Hirai, S., Yamaguchi, H., Harigaya, Y., Ishiguro, K., and Matsubara, E. (1991) Alpha 1-antichymotrypsin is present in diffuse senile plaques, Am. J. Pathol. 138, 247257.
Rozemuller, J.M., Abbink, J.J., Kamp, A.M., Stam, F.C., Hack, C.E., and Eikelenboom, P. (1991) Distribution pattern and functional state of al-antichymotrypsin in plaques and vascular amyloid in Alzheimer’s disease, Acta. Neuropathol. 82, 200–207.
Verbeek, M.M., Otte-Höller, I., Wesseling, P., Ruiter, D.J., and de Waal, R.M.W. (1996) Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the Aß-containing lesions in brains of patients with dementia of the Alzheimer type, Acta. Neuropathol. 91, 608–615.
Yamaguchi, H., Ishiguro, K., Sugihara, S., Nakazato, Y., Kawarabayashi, T., Sun, X., and Hirai, S. (1994) Presence of apolipoprotein Eon extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer 13-amyloid deposition, Acta. Neuropathol. 88, 413–419.
Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D., and Roses, A.D. (1993) Increased amyloid f3-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA 90, 9649–9653.
Snow, A.D., Mar, H., Nochlin, D., Sekiguchi, R.T., Kimata, K., Koike, Y., and Wight, T.N. (1990) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer’s disease and Down’s syndrome, Am. J. Pathol. 137, 1253–1270.
Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J., and Wight, T.N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer’s disease, Am. J Pathol. 133, 456–463.
Duong, T., Pommier, E.C., and Schiebel, A.B. (1989) Immunodetection of the amyloid P component in Alzheimer’s disease, Acta. Neuropathol. 78, 429–437.
Westermark, P., Shirahama, T., Skinner, M., Brun, A., Cameron, R., and Cohen, A.S. (1982) Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids, Lab. Invest. 46, 457–460.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D.A.C., Kondo, J., Ihara, Y., and Saitoh, T. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc. Natl. Acad. Sci. USA 90, 11282–11286.
Iwai, A., Yoshimoto, M., Masliah, E., and Saitoh, T. (1995) Non-A13 component of Alzheimer’s disease amyloid (NAC) is amyloidogenic, Biochemistry 34, 10139–10145.
Vinters, H.V., Lenard Secor, D., Pardridge, W.M., and Gray, F. (1990) Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy, Ann. Neurol. 28, 34–42.
Vinters, H.V., Nishimura, G.S., Lenard Secor, D., and Pardridge, W.M. (1990) Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer’s disease, Am. J. Pathol. 137, 233–240.
Tagliavini, F., Ghiso, J., Timmers, W.F., Giaccone, G., Bugiani, O., and Frangione, B. (1990) Coexistence of Alzheimer’s amyloid precursor protein and amyloid protein in cerebral vessel walls, Lab. Invest. 62, 761–767.
van Duinen, S.G., Maat-Schieman, M.L.C., Bruijn, J.A., Haan, J., and Roos, R.A.C. (1995) Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) contains various extracellular matrix deposits, Lab. Invest. 73, 183–189.
Zhang, W.W., Lempessi, H., and Olsson, Y. (1998) Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells, Acta Neuropathol. Berl. 96, 558–563.
Verbeek, M.M., Otte-Höller, I., Westphal, J.R., Wesseling, P., Ruiter, D.J., and de Waal, R.M.W. (1994) Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer’s disease, Am. J. Pathol. 144, 104–116.
Eikelenboom, P., Zhan, S.-S., van Gool, W.A., and Allsop, D. (1994) Inflammatory mechanisms in Alzheimer’s disease, Trends. Pharmacol. Sci. 15, 447–450.
Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeld-Jakob disease, Brain Res. 541, 163–166.
Lue, L.-F., Brachova, L., Civin, H., and Rogers, J. (1996) Inflammation, A(3 deposition, and neurofibrillary tangle formation as correlates of Alzheimer’s disease neurodegeneration, J. Neuropathol. Exp. Neurol. 55, 1083–1088.
Verbeek, M.M., Otte-Höller, I., Wesseling, P., Van Nostrand, W.E., Sorg, C., Ruiter, D.J., and de Waal, R.M.W. (1995) A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques, Acta. Neuropathol. 90, 493–503.
Rozemuller, J.M., Eikelenboom, P., Stam, F.C., Beyreuther, K., and Masters, C.L. (1989) A4 protein in Alzheimer’s disease: primary and secondary cellular events in extracellular amyloid deposition, J. Neuropathol. Exp. Neurol. 48, 674–691.
Haga, S., Akai, K., and Ishii, T. (1989) Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain, Acta. Neuropathol. 77, 569–575.
Ganter, U., Strauss, S., Jonas, U., Weidemann, A., Beyreuther, K., Volk, B., Berger, M., and Bauer, J. (1991) Alpha 2-macroglobulin synthesis in interleukin-6 stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer 3-amyloid precursor protein, FEBS Letters 282, 127–131.
Castel], J.V., Gomez-Lechôn, M.J., David, M., Andus, T., Geier, T., Trullenque, R., Farbra, R., and Heinrich, P.C. (1989) Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes, FEBS Letters 242, 237–239.
Das, S. and Potter, H. (1995) Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1, Neuron 14, 447–456.
Dustin, M.L., Rothlein, R., Bhan, A.K., Dinarello, C.A., and Springer, T.A. (1986) Induction by IL-1 and interferon: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1), J. Immunol. 137, 245–254.
Dickson, D.W., Lee, S.C., Mattiace, L.A., Yen, S.-H.C., and Brosnan, C. (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer’s disease, Glia 7, 75–83.
Griffin, W.S.T., Sheng, J.G., Roberts, G.W., and Mrak, R.E. (1995) Interleukin-1 expression in different plaque types in Alzheimer’s disease: Significance in plaque evolution, J. Neuropathol. Exp. Neurol. 54, 276–281.
Uchihara, T., Akiyama, H., Kondo, H., and Ikeda, K. (1997) Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer’s disease brain, Stroke 28, 1948–1950.
Maat, S.M., van-Duinen, S.G., Rozemuller, A.J., Haan, J., and Roos, R.A. (1997) Association of vascular amyloid beta and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease, J. Neuropathol. Exp. Neurol. 56, 273–284.
Verbeek, M.M., Otte-Höller, I., Ruiter, D.J., and de Waal, R.M.W. (1999) Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer’s disease, Cell. Mol. Biol. 45, 37–46.
Huang, J., Kim, L.J., Mealey, R., Marsh-HC, J., Zhang, Y., Tenner, A.J., Connolly-ES, J., and Pinsky, D.J. (1999) Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein, Science 285, 595–599.
Yamaguchi, H., Yamazaki, T., Lemere, C.A., Frosch, M.P., and Selkoe, D.J. (1992) Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer’s disease, Am. J. Pathol. 141, 249–259.
Narindrasorasak, S., Altman, R.A., Gonzalez-DeWhitt, P., Greenberg, B.D., and Kisilevsky, R. (1995) An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer’s disease, Lab. Invest. 72, 272–282.
Weller, R.O., Massey, A., Newman, T.A., Hutchings, M., Kuo, Y.M., and Roher, A.E. (1998) Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer’s disease, Am. J. Pathol. 153, 725–733.
Summers, J.B., Hill, W.D., Prendergast, M.A., and Buccafusco, J.J. (1998) Co-localization of apolipoprotein E and beta-amyloid in plaques and cerebral blood vessels of aged non-human primates, Alzheimer’s Reports 1, 119–128.
LaDu, M.J., Falduto, M.T., Manelli, A.M., Reardon, C.A., Getz, G.S., and Frail, D.E. (1994) Isoform-specific binding of Apolipoprotein E to 13-amyloid, J. Biol. Chem. 269, 23403–23406.
Castillo, G.M., Lukito, W., Wight, T.N., and Snow, A.D. (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation, J. Neurochem. 72, 1681–1687.
Bronfman, F.C., Garrido, J., Alvarez, A., Morgan, C., and Inestrosa, N.C. (1996) Laminin inhibits amyloid-beta-peptide fibrillation, Neurosci. Lett. 218, 201–203.
Rogers, J., Cooper, N.R., Webster, S., Schultz, J., McGeer, P.L., Styren, S.D., Civin, W.H., Brachova, L., Bradt, C., Ward, P., and Lieberburg, I. (1992) Complement activation by 13-amyloid in Alzheimer disease, Proc. Natl. Acad. Sci. USA 89, 10016–10020.
Olichney, J.M., Hansen, L.A., Galasko, D., Saitoh, T., Hofstetter, C.R., Katzman, R., and Thal, L.J. (1996) The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer’s disease and Lewy body variant, Neurology 47, 190–196.
Premkumar, D.R.D., Cohen, D.L., Hedera, P., Friedland, R.P., and Kalaria, R.N. (1996) Apolipoprotein E-c4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease, Am. J. Pathol. 148, 2083–2095.
Greenberg, S.M., Rebeck, G.W., Vonsattel, J.-P., Gomez-Isla, T., and Hyman, B.T. (1995) Apolipoprotein E c4 and cerebral hemorrhage associated with amyloid angiopathy, Ann. Neurol. 38, 254–259.
Greenberg, S.M., Vonsattel, J.P., Segal, A.Z., Chiu, R.I., Clatworthy, A.E., Liao, A., Hyman, B.T., and Rebeck, G.W. (1998) Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy, Neurology 50, 961–965.
Greenberg, S.M., Briggs, M.E., Hyman, B.T., Kokoris, G.J., Takis, C., Kanter, D.S., Kase, C.S., and Pessin, M.S. (1996) Apolipoprotein E e4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy, Stroke 27, 1333–1337.
Wisniewski, T., Castafo, E.M., Golabek, A., Vogel, T., and Frangione, B. (1994) Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro, Am. J. Pathol. 145, 1030–1035.
Zlokovic, B.V., Martel, C.L., Mackic, J.B., Matsubara, E., Wisniewski, T., McComb, J.G., Frangione, B., and Ghiso, J. (1994) Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer’s amyloid ß, Biochem. Biophys. Res. Commun. 205, 14311437.
Xu, P.T., Gilbert, J.R., Qiu, H.L., Ervin, J., Rothrock, C.T., Hulette, C., and Schmechel, D.E. (1999) Specific regional transcription of apolipoprotein E in human brain neurons, Am. J. Pathol. 154, 601–611.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
De Waal, R.M.W., Verbeek, M.M. (2000). Aβ-Associated Proteins in Cerebral Amyloid Angiopathy. In: Verbeek, M.M., de Waal, R.M.W., Vinters, H.V. (eds) Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related Disorders. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-1007-7_12
Download citation
DOI: https://doi.org/10.1007/978-94-017-1007-7_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5480-7
Online ISBN: 978-94-017-1007-7
eBook Packages: Springer Book Archive